Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth

Journal of Lipid Research

Volumn 46, Issue 2, 2005, Pages 320-327

  Stan, Simona ^a   Lambert, Marie ^a   Delvin, Edgard ^a   Paradis, Gilles ^b   O'Loughlin, Jennifer ^b   Hanley, James A ^b   Levy, Emile ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Apolipoprotein B; Children and adolescents; Cholesterol; Insulin resistance syndrome

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; DYSLIPIDEMIA; FEMALE; GENOTYPE; HUMAN; JUVENILE; LIPID ABSORPTION; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

EID: 13944254658     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400346-JLR200     Document Type: Article

References (47)

1. Davidson, N. O., and G. S. Shelness. 2000. Apolipoprotein B: mRNA editing, lipoprotein assembly, and presecretory degradation. Annu. Rev. Nutr. 20: 169-193.
2. Levy, E., and D. Menard. 2000. Developmental aspects of lipid and lipoprotein synthesis and secretion in human gut. Microsc. Res. Tech. 49: 363-373.
3. Burnett, J. R., J. Shan, B. A. Miskie, A. J. Whitfield J. Yuan, K. Tran, C. J. McKnight, R. A. Hegele, and Z. Yao. 2003. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. J. Biol. Chem. 278: 13442-13452.
4. Levy, E., C. C. Roy, L. Thibault, A. Bonin, P. Brochu, and E. G. Seidman. 1994. Variable expression of familial heterozygous hypobetalipoproteinemia: transient malabsorption during infancy. J. Lipid Res. 35: 2170-2177.
5. Wetterau, J. R., L. P. Aggerbeck, M. E. Bouma, C. Eisenberg, A. Munck, M. Hermier, J. Schmitz, G. Gay, D. J. Rader, and R. E. Gregg. 1992. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 258: 999-1001.
6. Levy, E., Y. Marcel, R. J. Deckelbaum, R. Milne, G. Lepage, E. Seidman, M. Bendayan, and C. C. Roy. 1987. Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease. J. Lipid Res. 28: 1263-1274.
7. Jones, B., E. L. Jones, S. A. Bonney, H. N. Patel, A. R. Mensenkamp, S. Eichenbaum-Voline, M. Rudling, U. Myrdal, G. Annesi, S. Naik, N. Meadows, A. Quattrone, S. A. Islam, R. P. Naoumova, B. Angelin, R. Infante, E. Levy, C. C. Roy, P. S. Freemont, J. Scott, and C. C. Shoulders. 2003. Mutations in a Sari GTPase of COPII vesicles are associated with lipid absorption disorders. Nat. Genet. 34: 29-31.
8. Siddiqi, S. A., F. S. Gorelick, J. T. Mahan, and C. M. Mansbach. 2003. COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle. J Cell Sci. 116: 415-427.
9. Levy, E. 1996. The genetic basis of primary disorders of intestinal fat transport. Clin. Invest. Med. 19: 317-324.
10. Haidari, M., N. Leung, F. Mahbub, K. D. Uffelman, R. Kohen-Avramoglu, G. F. Lewis, and K. Adeli. 2002. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and apoB48-containing lipoprotein overproduction. J. Biol. Chem. 277: 31646-31655.
11. Parks, E. J. 2001. Recent findings in the study of postprandial lipemia. Curr Atheroscler. Rep. 3: 462-470.
12. Zoltowska, M., E. Ziv, E. Delvin, D. Sinnett, R. Kalman, C. Garofalo, E. Seidman, and E. Levy. 2003: Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes. 52: 2539-2545.
13. Agren, J. J., R. Valve, H. Vidgren, M. Laakso, and M. Uusitupa. 1998. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler. Thromb. Vasc. Biol. 18: 1606-1610.
14. Levy, E., D. Menard, E. Delvin, S. Stan, G. Mitchell, M. Lambert, E. Ziv, J. C. Feoli-Fonseca, and E. Seidman. 2001. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J. Biol. Chem. 276: 39679-39684.
15. Baier, L. J., J. C. Sacchettini, W. C. Knowler, J. Eads, G. Paolisso, P. A. Tataranni, H. Mochizuki, P. H. Bennett, C. Bogardus, and M. Prochazka. 1995. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95: 1281-1287.
16. Galluzzi, J. R., L. A. Cupples, J. B. Meigs, P. W. Wilson, E. J. Schaefer, and J. M. Ordovas. 2001. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care. 24: 1161-1166.
17. Pihlajamaki, J., J. Rissanen, S. Heikkinen, L. Karjalainen, and M. Laakso. 1997. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 17: 1039-1044.
18. Sipilainen, R., M. Uusitupa, S. Heikkinen, A. Rissanen, and M. Laakso. 1997. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J. Clin. Endocrinol. Metab. 82: 2629-2632.
19. Chiu, K. C., L. M. Chuang, A. Chu, and C. Yoon. 2001. Fatty acid binding protein 2 and insulin resistance. Eur. J. Clin. Invest. 31: 521-527.
20. Ledmyr, H., F. Karpe, B. Lundahl, M. McKinnon, C. Skoglund-Andersson, and E. Ehrenborg. 2002. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J. Lipid Res. 43: 51-58.
21. Juo, S. H., Z. Han, J. D. Smith, L. Colangelo, and K. Liu. 2000. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, apoB, and triglyceride levels in young African American men: results from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler. Thromb. Vasc. Biol. 20: 1316-1322.
22. Ma, Y., H. E. Henderson, V. Murthy, G. Roederer, M. V. Monsalve, L. A. Clarke, T. Normand, P. Julien, C. Gagne, and M. Lambert. 1991. A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N. Engl. J. Med. 324: 1761-1766.
23. Leitersdorf, E., E. J. Tobin, J. Davignon, and H. H. Hobbs. 1990. Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85: 1014-1023.
24. De Braekeleer, M., C. Dionne, C. Gagne, P. Julien, D. Brun, M. R. Ven Murthy, and P. J. Lupien. 1991. Founder effect in familial hyperchylomicronemia among French Canadians of Quebec. Hum. Hered. 41: 168-173.
25. Allard, P., E. E. Delvin, G. Paradis, J. A. Hanley, J. O'Loughlin, C. Lavallee, E. Levy, and M. Lambert. 2003. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin. Chem. 49: 644-649.
26. Paradis, G., M. Lambert, J. O'Loughlin, C. Lavallee, J. Aubin, P. Berthiaume, M. Ledoux, E. E. Delvin, E. Levy, and J. A. Hanley. 2003. The Quebec Child and Adolescent Health and Social Survey: design and methods of a cardiovascular risk factor survey for youth. Can. J. Cardiol. 19: 523-531.
27. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. 2004. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 114: 555-576.
28. Karpe, F., B. Lundahl, E. Ehrenborg, P. Eriksson, and A. Hamsten. 1998. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler. Thromb. Vasc. Biol. 18: 756-761.
29. Yasuda, N., and M. Kimura. 1968. A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann. Hum. Genet. 31: 409-420.
30. Galluzzi, J. R., L. A. Cupples, J. D. Otvos, P. W. Wilson, E. J. Schaefer, and J. M. Ordovas. 2001. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis. 159: 417-424.
31. Mitchell, B. D., C. M. Kammerer, P. O'Connell, C. R. Harrison, M. Manire, P. Shipman, M. P. Moyer, M. P. Stern, and M. L. Frazier. 1995. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes. 44: 1046-1053.
32. Yamada, K., X. Yuan, S. Ishiyama, K. Koyama, F. Ichikawa, A. Koyanagi, W. Koyama, and K. Nonaka. 1997. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 40: 706-710.
33. Lewis, G. F., A. Carpentier, K. Adeli, and A. Giacca. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23: 201-229.
34. Vassileva, G., L. Huwyler, K. Poirier, L. B. Agellon, and M. J. Toth. 2000. The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J. 14: 2040-2046.
35. Agellon, L. B., M. J. Toth, and A. B. Thomson. 2002. Intracellular lipid binding proteins of the small intestine. Mol. Cell. Biochem. 239: 79-82.
36. Shen, H., P. Howles, and P. Tso. 2001. From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons. Adv. Drug Deliv. Rev. 50 (Suppl. 1): 103-125.
37. Campagna, F., A. Montali, M. G. Baroni, A. T. Maria, G. Ricci, R. Antonini, R. Verna, and M. Area. 2002. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia. Metabolism. 51: 1298-1305.
38. Baier, L. J., C. Bogardus, and J. C. Sacchettini. 1996. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271: 10892-10896.
39. Hegele, R. A., T. M. Wolever, J. A. Story, P. W. Connelly, and D. J. Jenkins. 1997. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur. J. Clin. Invest. 27: 857-862.
40. Damcott, C. M., E. Feingold, S. P. Moffett, M. M. Barmada, J. A. Marshall, R. F. Hamman, and R. E. Ferrell. 2003. Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum. Genet. 112: 610-616.
41. Formanack, M. L., and L. J. Baier. 2004. Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia. 47: 349-351.
42. Gordon, D. A., and H. Jamil. 2000. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim. Biophys. Acta. 1486: 72-83.
43. Chen, S. P., K. C. Tan, and K. S. Lam. 2003. Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions. Atherosclerosis. 167: 287-292.
44. Ledmyr, H., F. Karpe, B. Lundahl, M. McKinnon, C. Skoglund-Andersson, and E. Ehrenborg. 2002. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J. Lipid Res. 43: 51-58.
45. Couture, P., J. D. Otvos, L. A. Cupples, P. W. Wilson, E. J. Schaefer, and J. M. Ordovas. 2000. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis. 148: 337-343.
46. Hagan, D. L., B. Kienzle, H. Jamil, and N. Hariharan. 1994. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J. Biol. Chem. 269: 28737-28744.
47. Lin, M. C., D. Gordon, and J. R. Wetterau. 1995. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J. Lipid Res. 36: 1073-1081.